From: Post-infection cognitive impairments in a cohort of elderly patients with COVID-19
 | Patients included (n = 1539) | Patients not included (n = 1694) | P value |
---|---|---|---|
Age – Median (IQR), year | 69 (66, 75) | 70 (66, 75) | 0.165a |
Male – No. (%) | 738 (47.95) | 826 (48.76) | 0.647b |
Education – Median (IQR), year | 12 (9–12) | 12 (9–12) | 0.226a |
BMI – Median (IQR) | 23.97 (22.52, 25.38) | 23.92 (22.42, 25.41) | 0.284a |
Severe cases -No. (%) | 238 (15.46) | 257 (15.17) | 0.845b |
Coexisting disorders – No. (%) | |||
 Hypertension | 589 (38.27) | 640 (37.78) | 0.800b |
 Diabetes mellitus | 304 (19.75) | 348 (20.54) | 0.599b |
 Hyperlipidaemia | 155 (10.07) | 176 (10.39) | 0.772b |
 Stroke history | 87 (5.65) | 91 (5.37) | 0.758b |
 Coronary heart disease history | 212 (13.78) | 231 (13.64) | 0.919b |
 COPD | 150 (9.75) | 163 (9.62) | 0.905b |
ICU admission – No. (%) | 81 (5.26) | 94 (5.55) | 0.756b |
Mechanical Ventilation, No. (%) | 96 (6.24) | 106 (6.26) | 1.000b |
High flow oxygen therapy, No. (%) | 326 (21.18) | 355 (20.96) | 0.897b |
Delirium, No. (%) | 105 (6.82) | 117 (6.91) | 0.945b |